Shares of Moderna jumped over 8% to a record closing high ahead of its upcoming earnings announcement.
Moderna stated that the FDA granted fast track designation for its vaccine candidate against a respiratory syncytial virus.
General Motors missed Wall Street’s earnings expectations for the second quarter despite a record operating profit.
GM shares were down by as much as 9.8% during intraday and it was the company’s worst daily loss by percentage since the beginning of the coronavirus pandemic.
Timestamps:
- MRNA 02:00
- GM 03:15